Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Investigation|August 1, 1987
Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myelomaB Simonsson, G Brenning, C Källander, et al.
British Journal of Haematology|January 1, 1986
Pretreatment serum beta 2-microglobulin in multiple myelomaG Brenning, B Simonsson, C Källander, et al.
British Journal of Haematology|October 1, 1985
Evaluation of serum deoxythymidine kinase as a marker in multiple myelomaB Simonsson, C F Källander, G Brenning, et al.
Scandinavian Journal of Haematology|November 1, 1985
Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myelomaG Brenning, A Ahre, K Nilsson
British Journal of Haematology|May 1, 1988
Biochemical markers in multiple myeloma: a multivariate analysisB Simonsson, C F Källander, G Brenning, et al.
Scandinavian Journal of Haematology|July 1, 1985
Alpha interferon treatment of patients with hairy-cell leukaemiaH Hagberg, G Alm, M Björkholm, et al.
European Journal of Haematology|August 1, 1988
High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS)A Ahre, M Björkholm, A Osterborg, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central SwedenA Osterborg, A Ahre, M Björkholm, et al.
Cancer Treatment Reports|November 1, 1984
Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central SwedenA Ahre, M Björkholm, H Mellstedt, et al.
European Journal of Haematology|July 1, 1989
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCSA Osterborg, A Ahre, M Björkholm, et al.
Pageof 14